Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.21.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash Flow from Operating Activities:              
Net income (loss) available to common stockholders $ (3,456) $ (12,850) $ (1,728) $ (9,488) $ 8,470 $ (29,654)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Shares and warrants issued to third parties for services         46 10,182  
Depreciation and amortization         1,255 1,298  
Amortization of debt issuance costs and discounts         1,785 3,723  
Share-based compensation         3,517 7,047  
Change in fair value of warrant liabilities (590)   (4,213)   (23,463) (2,118)  
PIK interest expense on notes payable     500   1,110 1,465  
Amortization of prepaid advertising         891 0  
Other         (981) 772  
Changes in operating assets and liabilities:              
Accounts receivable, net         (2,893) 195  
Inventories, net         1,445 1,458  
Prepaid expenses and other assets         680 224  
Accounts payable and accrued liabilities         (8) 691  
Other         (174) 194  
Cash Used in Operating Activities         (8,320) (4,523)  
Cash Flow from Investing Activities              
Acquisition of property and equipment         (124) (42)  
Cash Used in Investing Activities         (124) (42)  
Cash Flow from Financing Activities              
Proceeds from shares and warrants issued pursuant to private placement, net         4,012 0  
Share repurchases         (1,274) 0  
Proceeds from issuance of debt         0 2,352  
Proceeds from revolving lines of credit         5,535 6,624  
Payments on revolving lines of credit         (5,883) (6,297)  
Proceeds from term loan         6,000 0  
Payments on term loans         (8,379) 0  
Proceeds from investor prepayment         0 1,518  
Cash received for warrant exercises         1,685 0  
IPO proceeds, net         36,160 0  
Debt issuance costs         (140) (85)  
Cash Provided by Financing Activities         37,716 4,112  
Net (decrease) increase in cash and cash equivalents and restricted cash         29,272 (453)  
Total cash and cash equivalents and restricted cash, beginning of period   $ 3,989   $ 2,534 3,989 2,534 $ 2,534
Total cash and cash equivalents and restricted cash, end of period $ 33,261   $ 2,081   33,261 2,081 $ 3,989
Cash paid during the period for:              
Interest         292 1,729  
Non-cash financing and investing transactions              
Stock issued for services         0 125  
ABL guarantor warrants         $ 0 $ 230